Key Account Director - Kentucky/West Virginia

Role: Key Account Director responsible for driving access and adoption of Rezdiffra (resmetirom) for MASH treatment within regional IDNs and HCP Super Groups. Responsibilities include engaging with healthcare executives, articulating clinical and economic value propositions, developing strategic account plans, and fostering collaboration across sales, medical, marketing, and market access teams. The role emphasizes building strong stakeholder relationships, providing disease insight on MAFLD/MASH, and ensuring compliance with applicable regulations. Qualifications: Bachelor's degree; 12+ years of account management experience within biotech or pharma; extensive relationships with key medical and RX decision-makers; proven track record of exceeding targets; strong project management, communication, and analytical skills. Requirements include ability to travel 60-80%, reside within the geographic area, and proficiency in MS Office tools. High-value specifics: Focus on metabolic liver disease (MAFLD/MASH), specific to the Phase 3 outcomes trial for MASH cirrhosis, with an emphasis on health systems engagement and key stakeholder management. Reporting to the Executive Director, Health Systems, the position involves strategic account management in a complex, matrixed environment with a focus on liver disease therapeutics.